Canada · Delayed Price · Currency is CAD CareRx Statistics
Total Valuation
CareRx has a market cap or net worth of CAD 240.32 million. The enterprise value is 304.32 million.
| Market Cap | 240.32M |
| Enterprise Value | 304.32M |
Important Dates
The last earnings date was Wednesday, March 4, 2026.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | Mar 19, 2026 |
Share Statistics
CareRx has 62.91 million shares outstanding. The number of shares has increased by 7.03% in one year.
| Current Share Class | 62.91M |
| Shares Outstanding | 62.91M |
| Shares Change (YoY) | +7.03% |
| Shares Change (QoQ) | -1.22% |
| Owned by Insiders (%) | 1.18% |
| Owned by Institutions (%) | 37.49% |
| Float | 33.85M |
Valuation Ratios
The trailing PE ratio is 9.32 and the forward PE ratio is 18.48.
| PE Ratio | 9.32 |
| Forward PE | 18.48 |
| PS Ratio | 0.65 |
| PB Ratio | 2.19 |
| P/TBV Ratio | 22.66 |
| P/FCF Ratio | 9.53 |
| P/OCF Ratio | 7.80 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.29, with an EV/FCF ratio of 12.06.
| EV / Earnings | 11.65 |
| EV / Sales | 0.82 |
| EV / EBITDA | 10.29 |
| EV / EBIT | 26.69 |
| EV / FCF | 12.06 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.06 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 2.64 |
| Debt / FCF | 3.09 |
| Interest Coverage | 1.72 |
Financial Efficiency
Return on equity (ROE) is 26.97% and return on invested capital (ROIC) is 6.97%.
| Return on Equity (ROE) | 26.97% |
| Return on Assets (ROA) | 3.06% |
| Return on Invested Capital (ROIC) | 6.97% |
| Return on Capital Employed (ROCE) | 6.34% |
| Weighted Average Cost of Capital (WACC) | 7.67% |
| Revenue Per Employee | 249,657 |
| Profits Per Employee | 17,618 |
| Employee Count | 1,533 |
| Asset Turnover | 1.59 |
| Inventory Turnover | 14.73 |
Taxes
| Income Tax | -22.77M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.01% in the last 52 weeks. The beta is 0.68, so CareRx's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +42.01% |
| 50-Day Moving Average | 3.81 |
| 200-Day Moving Average | 3.44 |
| Relative Strength Index (RSI) | 55.97 |
| Average Volume (20 Days) | 55,711 |
Short Selling Information
The latest short interest is 865, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 865 |
| Short Previous Month | 1,548 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CareRx had revenue of CAD 370.24 million and earned 26.13 million in profits. Earnings per share was 0.41.
| Revenue | 370.24M |
| Gross Profit | 110.96M |
| Operating Income | 11.40M |
| Pretax Income | 3.35M |
| Net Income | 26.13M |
| EBITDA | 25.54M |
| EBIT | 11.40M |
| Earnings Per Share (EPS) | 0.41 |
Balance Sheet
The company has 13.92 million in cash and 77.93 million in debt, with a net cash position of -64.01 million or -1.02 per share.
| Cash & Cash Equivalents | 13.92M |
| Total Debt | 77.93M |
| Net Cash | -64.01M |
| Net Cash Per Share | -1.02 |
| Equity (Book Value) | 109.50M |
| Book Value Per Share | 1.74 |
| Working Capital | 3.98M |
Cash Flow
In the last 12 months, operating cash flow was 30.81 million and capital expenditures -5.59 million, giving a free cash flow of 25.23 million.
| Operating Cash Flow | 30.81M |
| Capital Expenditures | -5.59M |
| Depreciation & Amortization | 14.14M |
| Net Borrowing | -10.96M |
| Free Cash Flow | 25.23M |
| FCF Per Share | 0.40 |
Margins
Gross margin is 29.97%, with operating and profit margins of 3.08% and 7.06%.
| Gross Margin | 29.97% |
| Operating Margin | 3.08% |
| Pretax Margin | 0.91% |
| Profit Margin | 7.06% |
| EBITDA Margin | 6.90% |
| EBIT Margin | 3.08% |
| FCF Margin | 6.81% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 2.09%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 2.09% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 4.82% |
| Buyback Yield | -7.03% |
| Shareholder Yield | -4.94% |
| Earnings Yield | 10.87% |
| FCF Yield | 10.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 25, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
CareRx has an Altman Z-Score of 1.02 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.02 |
| Piotroski F-Score | 7 |